Newsroom
Sorted by: Latest
-
Murata beginnt Massenproduktion des weltweit kleinsten 3-Terminal-Low-ESL-MLCC im 0201-Zoll-Format
KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKIO: 6981) (ISIN: JP3914400001) hat mit der Serienproduktion der LLD-Serie begonnen, der weltweit kleinsten* Drei-Terminal-Low-ESL (Ersatz-Serieninduktivität) Mehrschichtkeramikkondensatoren (MLCC). Mit einer Größe von nur 0201 Zoll (0,6 x 0,3 mm) reduzieren die neuen Produkte den Montageflächenbedarf um rund 64 Prozent im Vergleich zu dem bisher kleinsten Modell von Murata mit 0402 Zoll (1,0 x 0,5 mm), was in Kompaktgeräten wie S...
-
Murata lance la production en série des condensateurs céramiques multicouches à faible ESL et à trois bornes au format 0201, les plus petits au monde
KYOTO, Japon--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO : 6981) (ISIN : JP3914400001) a lancé la production en série de la gamme LLD, les condensateurs céramiques multicouches (MLCC) à trois bornes et à faible inductance équivalente (ESL) les plus petits au monde*. D’une taille de seulement 0201 pouces (0,6 × 0,3 mm), ces nouveaux produits réduisent la surface de montage d’environ 64 % par rapport au précédent modèle le plus petit de Murata, de taille 0402 pouces (1,0 × 0,5 mm), li...
-
Samenvatting: Murata begint met de massaproductie van ’s werelds kleinste 0201-inch MLCC’s met drie aansluitingen en een lage ESL
KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) is begonnen met de massaproductie van de LLD-serie, ’s werelds kleinste* meerlaagse keramische condensatoren (MLCC’s) met drie aansluitingen en een lage equivalente serie-inductie (ESL). Met een afmeting van slechts 0201 inch (0,6 × 0,3 mm) verminderen de nieuwe producten de inbouwruimte met ongeveer 64% in vergelijking met Murata’s vorige kleinste model van 0402 inch (1,0 × 0,5 mm). In compacte app...
-
شركة Andersen Global تعزّز حضورها في الأرجنتين بالتعاون مع Fidem Partners
سان فرانسيسكو--(BUSINESS WIRE)--تعمل Andersen Global على تعزيز قدراتها في مجالَي الضرائب والمعاملات في الأرجنتين من خلال اتفاقية تعاون مع Fidem Partners، ما يعزّز حضورها وعروض خدماتها في السوق.تقدم شركة Fidem Partners، التي تأسست في عام 2011، الاستشارات للشركات في مجالات الضرائب والامتثال، وعمليات الاندماج والاستحواذ، والاستعانة بمصادر خارجية لإدارة العمليات التجارية. كما تقدم الشركة خدماتها المتميزة إلى شركات في قطاعات الطاقة والتكنولوجيا والخدمات المالية والأعمال الزراعية والسلع الاستهلاكية، م...
-
Founder and CEO J.W. Roth Named CEO of the Year at 2026 Southern Colorado Best in Business Awards
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation (“VENU” or the “Company”) (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that its Founder, Chairman and CEO J.W. Roth has been named CEO of the Year at the Southern Colorado Business Forum & Digest 2026 Best in Business Awards. The community-voted awards recognize leaders and organizations moving the regional economy forward. "This one means a lot because...
-
VICI Properties Inc. Announces Release Date for Third Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced today that it will release its third quarter 2026 financial results on Wednesday October 28, 2026 after the close of trading on the New York Stock Exchange. The Company will host a conference call and audio webcast on Thursday, October 29, 2026 at 10:00 a.m. Eastern Time (ET).Conference Call and WebcastPlease visit the VICI Properties website to listen to the earnings call via a live webca...
-
Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today provided an update that its partner, Pierre Fabre Pharmaceuticals, Inc. (PFP), has resubmitted the tabelecleucel Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA). “We are grateful to...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Space Economy UCITS ETF 29.09.2026 FSPC.LN IE000ANMCD25 50,002.00 USD 987,321.27 19.746 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 29.09.2026 UINC IE00BZBW4Z27 10,670,055.00 USD 415,376,105.88 38.929 ...
-
46% Have Shipped Failed AI Code, Yet 69% Are Still Confident in It, New SmartBear Survey Finds
SOMERVILLE, Mass.--(BUSINESS WIRE)--SmartBear's 2026 State of Software Quality and Testing report finds leaders' blind trust in AI code also shows up in how they validate and govern it....